203 related articles for article (PubMed ID: 34203429)
1. Level of Murine DDX3 RNA Helicase Determines Phenotype Changes of Hepatocytes In Vitro and In Vivo.
Sergeeva O; Abakumova T; Kurochkin I; Ialchina R; Kosyreva A; Prikazchikova T; Varlamova V; Shcherbinina E; Zatsepin T
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34203429
[TBL] [Abstract][Full Text] [Related]
2. DDX3 as a strongest prognosis marker and its downregulation promotes metastasis in colorectal cancer.
Su CY; Lin TC; Lin YF; Chen MH; Lee CH; Wang HY; Lee YC; Liu YP; Chen CL; Hsiao M
Oncotarget; 2015 Jul; 6(21):18602-12. PubMed ID: 26087195
[TBL] [Abstract][Full Text] [Related]
3. DEAD-box RNA Helicase DDX3: Functional Properties and Development of DDX3 Inhibitors as Antiviral and Anticancer Drugs.
Kukhanova MK; Karpenko IL; Ivanov AV
Molecules; 2020 Feb; 25(4):. PubMed ID: 32102413
[TBL] [Abstract][Full Text] [Related]
4. DDX3, a DEAD box RNA helicase, is deregulated in hepatitis virus-associated hepatocellular carcinoma and is involved in cell growth control.
Chang PC; Chi CW; Chau GY; Li FY; Tsai YH; Wu JC; Wu Lee YH
Oncogene; 2006 Mar; 25(14):1991-2003. PubMed ID: 16301996
[TBL] [Abstract][Full Text] [Related]
5. NZ51, a ring-expanded nucleoside analog, inhibits motility and viability of breast cancer cells by targeting the RNA helicase DDX3.
Xie M; Vesuna F; Botlagunta M; Bol GM; Irving A; Bergman Y; Hosmane RS; Kato Y; Winnard PT; Raman V
Oncotarget; 2015 Oct; 6(30):29901-13. PubMed ID: 26337079
[TBL] [Abstract][Full Text] [Related]
6. Expression of the RNA helicase DDX3 and the hypoxia response in breast cancer.
Bol GM; Raman V; van der Groep P; Vermeulen JF; Patel AH; van der Wall E; van Diest PJ
PLoS One; 2013; 8(5):e63548. PubMed ID: 23696831
[TBL] [Abstract][Full Text] [Related]
7. DDX3 modulates cell adhesion and motility and cancer cell metastasis via Rac1-mediated signaling pathway.
Chen HH; Yu HI; Cho WC; Tarn WY
Oncogene; 2015 May; 34(21):2790-800. PubMed ID: 25043297
[TBL] [Abstract][Full Text] [Related]
8. RNA helicase DDX3: a novel therapeutic target in Ewing sarcoma.
Wilky BA; Kim C; McCarty G; Montgomery EA; Kammers K; DeVine LR; Cole RN; Raman V; Loeb DM
Oncogene; 2016 May; 35(20):2574-83. PubMed ID: 26364611
[TBL] [Abstract][Full Text] [Related]
9. DDX3 DEAD-box RNA helicase is required for hepatitis C virus RNA replication.
Ariumi Y; Kuroki M; Abe K; Dansako H; Ikeda M; Wakita T; Kato N
J Virol; 2007 Dec; 81(24):13922-6. PubMed ID: 17855521
[TBL] [Abstract][Full Text] [Related]
10. Murine cytomegaloviruses m139 targets DDX3 to curtail interferon production and promote viral replication.
Puhach O; Ostermann E; Krisp C; Frascaroli G; Schlüter H; Brinkmann MM; Brune W
PLoS Pathog; 2020 Oct; 16(10):e1008546. PubMed ID: 33031466
[TBL] [Abstract][Full Text] [Related]
11. DEAD/H BOX 3 (DDX3) helicase binds the RIG-I adaptor IPS-1 to up-regulate IFN-beta-inducing potential.
Oshiumi H; Sakai K; Matsumoto M; Seya T
Eur J Immunol; 2010 Apr; 40(4):940-8. PubMed ID: 20127681
[TBL] [Abstract][Full Text] [Related]
12. (DEAD)-box RNA helicase 3 modulates NF-κB signal pathway by controlling the phosphorylation of PP2A-C subunit.
Wang X; Wang R; Luo M; Li C; Wang HX; Huan CC; Qu YR; Liao Y; Mao X
Oncotarget; 2017 May; 8(20):33197-33213. PubMed ID: 28402257
[TBL] [Abstract][Full Text] [Related]
13. Cytoplasmic DDX3 as prognosticator in male breast cancer.
van der Pol CC; Moelans CB; Manson QF; Batenburg MCT; van der Wall E; Borel Rinkes I; Verkooijen L; Raman V; van Diest PJ
Virchows Arch; 2021 Oct; 479(4):647-655. PubMed ID: 33974127
[TBL] [Abstract][Full Text] [Related]
14. DDX3, a potential target for cancer treatment.
Bol GM; Xie M; Raman V
Mol Cancer; 2015 Nov; 14():188. PubMed ID: 26541825
[TBL] [Abstract][Full Text] [Related]
15. A double-edged function of DDX3, as an oncogene or tumor suppressor, in cancer progression (Review).
He Y; Zhang D; Yang Y; Wang X; Zhao X; Zhang P; Zhu H; Xu N; Liang S
Oncol Rep; 2018 Mar; 39(3):883-892. PubMed ID: 29328432
[TBL] [Abstract][Full Text] [Related]
16. DDX3 RNA helicase is required for HIV-1 Tat function.
Yasuda-Inoue M; Kuroki M; Ariumi Y
Biochem Biophys Res Commun; 2013 Nov; 441(3):607-11. PubMed ID: 24183723
[TBL] [Abstract][Full Text] [Related]
17. The Ded1/DDX3 subfamily of DEAD-box RNA helicases.
Sharma D; Jankowsky E
Crit Rev Biochem Mol Biol; 2014; 49(4):343-60. PubMed ID: 25039764
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological inhibition of DEAD-Box RNA Helicase 3 attenuates stress granule assembly.
Cui BC; Sikirzhytski V; Aksenova M; Lucius MD; Levon GH; Mack ZT; Pollack C; Odhiambo D; Broude E; Lizarraga SB; Wyatt MD; Shtutman M
Biochem Pharmacol; 2020 Dec; 182():114280. PubMed ID: 33049245
[TBL] [Abstract][Full Text] [Related]
19. Viral infection-induced changes in the expression profile of non-RLR DExD/H-box RNA helicases (DDX1, DDX3, DHX9, DDX21 and DHX36) in zebrafish and common carp.
Mojzesz M; Klak K; Wojtal P; Adamek M; Podlasz P; Chmielewska-Krzesinska M; Matras M; Reichert M; Chadzinska M; Rakus K
Fish Shellfish Immunol; 2020 Sep; 104():62-73. PubMed ID: 32526283
[TBL] [Abstract][Full Text] [Related]
20. Ezrin Binds to DEAD-Box RNA Helicase DDX3 and Regulates Its Function and Protein Level.
Çelik H; Sajwan KP; Selvanathan SP; Marsh BJ; Pai AV; Kont YS; Han J; Minas TZ; Rahim S; Erkizan HV; Toretsky JA; Üren A
Mol Cell Biol; 2015 Sep; 35(18):3145-62. PubMed ID: 26149384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
